Fibrin sealants in clinical practice

Area of Science:

• Biomaterials Science
• Surgical Innovation
• Hemostasis Research

Background:

• Fibrin sealants are critical surgical adjuncts for hemostasis, tissue sealing, and wound healing.
• Their efficacy is influenced by variations in fibrinogen and thrombin concentrations, impacting clot strength and formation speed.
• Additional components like factor XIII and antifibrinolytic agents modulate clot stability and longevity.

Purpose of the Study:

• To review the composition and properties of fibrin sealants.
• To discuss how variations in fibrin sealant composition affect their surgical utility.
• To highlight the impact of commercialization and standardization on fibrin sealant performance.

Main Methods:

• Literature review of fibrin sealant composition and properties.
• Analysis of the relationship between sealant components and clot characteristics.
• Discussion of clinical implications and surgical applications.

Main Results:

• Fibrinogen concentration dictates clot strength; thrombin concentration influences clotting speed.
• Factor XIII enhances clot tensile strength and stability.
• Antifibrinolytic agents prolong clot lifespan by inhibiting fibrinolysis.
• Viscosity of fibrinogen affects ease of application, particularly via catheters.
• Commercial fibrin sealants offer consistent composition compared to 'home-brew' preparations, improving predictable performance.

Conclusions:

• Variations in fibrin sealant composition significantly alter clot properties and surgical applicability.
• Standardized commercial fibrin sealants promise more consistent and reliable performance in diverse surgical settings.
• Improved understanding and consistency are expected to expand the use of fibrin sealants in surgery.